|
Volume 15, Issue 8, August 2008, in PDF
|
   |
Article: 562
Central and Eastern Europe:
Growth Opportunities, Growing Pains
Given the uneven length of global
clinical trial experience in CEE countries, many industry insiders consider
that the region has both emerging and “emerged” countries. Growth is expected
to continue generally in the CEE region, perhaps more quickly in the largest
countries, such as Russia
and Ukraine.
Article: 563
No Fazing Phase I Growth
Phase I studies have become more complex as drug sponsors want critical
data about their compounds to help inform decision-making and avoid expensive
late-phase failures.
Article: 564
CRAcademy Offers New CRA Training Model in Europe
As most industry insiders will acknowledge, the clinical research
employment market has undergone a shift—on a global scale—from being
employer-driven to candidate-driven. Difficulties finding and keeping qualified
clinical trials personnel in Europe and
elsewhere have grown. Observers agree that the available workforce simply isn’t
large enough to meet staffing needs. Experienced and inexperienced
professionals alike are capitalizing on the clinical research industry’s staffing
shortfalls.
Article: 565
Eye On:Allergies
Allergic reactions are defined as abnormal, excessive responses of the
immune system in response to an otherwise harmless, foreign protein known as an
allergen. Individuals who are genetically predisposed to a specific allergy or
to multiple allergies mount an immune response via lymphocytes, immunoglobulin
E (IgE) antibodies, inflammatory mediators and mast cells. This results in
symptoms involving the target organs, namely, the nose, eyes, bronchial tubes,
skin and gastrointestinal tract.
Price: $59.00
|
